Company / Gross Profit per Share
Edwards Lifesciences Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$8.15
FY2025
5-year range
$6.15 / $8.15
FY2021-FY2025
Trend
+13.4%
vs FY2024
Sector context
#58 of 99
Health Care
What the data says
At $8.15, Edwards Lifesciences's gross profit per share ranks #58 of 99 in the Health Care sector. Gross Profit per Share has increased for 3 consecutive years, from $6.15 in FY2022 to $8.15 in FY2025.
Based on SEC 10-K filings.
8.15 in FY2025 with a 5-year CAGR of +9.0%.
Improved from $6.55 to $8.15 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
#58 of 99 in Health CareTop 59% of 99This company $8.15 Sector average $13.99
▼
-41.7% below sector average
Key checks
Key Insights
- Edwards Lifesciences's gross profit per share has grown for 3 consecutive years.
- In FY2025, gross profit per share increased 13.4% year-over-year.
- Ranks #58 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.15 | +13.4% |
| FY2024 | $7.19 | +9.8% |
| FY2023 | $6.55 | +6.5% |
| FY2022 | $6.15 | -3.7% |
| FY2021 | $6.38 | +20.5% |
| FY2020 | $5.30 | -65.8% |
| FY2019 | $15.46 | +15.4% |
| FY2018 | $13.40 | +10.8% |
| FY2017 | $12.10 | +18.2% |
| FY2016 | $10.24 | -41.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026